What is the upper limit of Perindopril (Angiotensin-Converting Enzyme Inhibitor) dosing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The upper limit of perindopril dosing is 16 mg once daily for most patients. For hypertension, the typical starting dose is 4 mg once daily, which can be titrated up to 8 mg daily if needed for blood pressure control. For heart failure, treatment usually begins at 2 mg daily and can be increased gradually to the maximum 16 mg daily as tolerated. Patients with renal impairment (creatinine clearance less than 60 mL/min) should receive lower doses, typically starting at 2 mg daily with a maximum of 8 mg daily. Elderly patients should also start at lower doses (2-4 mg daily) due to potential decreased renal function. Perindopril is an ACE inhibitor that works by preventing the conversion of angiotensin I to angiotensin II, thereby reducing vasoconstriction and sodium retention. Patients should be monitored for hypotension, hyperkalemia, and changes in renal function, particularly when initiating therapy or increasing doses. The medication should be taken at the same time each day, typically in the morning, and can be taken with or without food.

Key Considerations

  • The maximum dose of perindopril is supported by the most recent guidelines, including the 2022 AHA/ACC/HFSA guideline for the management of heart failure 1.
  • Renal function and age should be considered when determining the initial and maximum doses of perindopril.
  • Monitoring for potential side effects, such as hypotension and hyperkalemia, is crucial when initiating or adjusting perindopril therapy.

Dosage Recommendations

  • Initial dose: 4 mg once daily for hypertension, 2 mg once daily for heart failure
  • Maximum dose: 16 mg once daily for most patients, 8 mg once daily for patients with renal impairment
  • Titration: increase dose gradually as needed and tolerated

Important Interactions and Precautions

  • Monitor renal function and electrolyte levels, particularly potassium, when initiating or adjusting perindopril therapy.
  • Use with caution in patients with renal impairment, heart failure, or a history of angioedema.

From the FDA Drug Label

DOSAGE AND ADMINISTRATION ... The dosage may be titrated upward until blood pressure, when measured just before the next dose, is controlled or to a maximum of 16 mg per day.

The upper limit of Perindopril dosing is 16 mg per day 2.

From the Research

Upper Limit of Perindopril Dosing

  • The upper limit of Perindopril dosing is not explicitly stated in the provided studies, but the maximum recommended dose mentioned is 8 mg once daily 3, 4.
  • In one study, the daily dose of perindopril was increased by 4 mg every 4 weeks to a maximum of 16 mg per day, but it was found that the dose-response curve flattened after 8 mg per day 5.
  • Another study found that uptitration to high-dose perindopril (up to 8 mg once daily) was required in 46% of patients with one additional risk factor and 64% of patients with more than four additional risk factors 4.
  • The studies suggest that perindopril is effective and well-tolerated at doses ranging from 4 to 8 mg once daily, but the optimal dose may vary depending on individual patient characteristics and response to treatment 3, 4, 6, 7, 5.

Dosing Regimens

  • Perindopril can be administered once daily, with a daily dose of 4 to 8 mg being effective in reducing blood pressure 3, 4, 6, 7.
  • One study compared once-daily and twice-daily administration of perindopril and found no difference in arterial pressure reduction or response rate between the two regimens 5.
  • The studies suggest that perindopril is suitable for once-daily administration, but the optimal dosing regimen may depend on individual patient characteristics and response to treatment 3, 4, 6, 7, 5.

Related Questions

What is the effect of Perindopril (Angiotensin-Converting Enzyme Inhibitor)?
What is the recommended treatment regimen for Perindopril (Angiotensin-Converting Enzyme inhibitor) in patients with hypertension and heart failure?
Is perindopril suitable for patients with impaired renal function?
What is the next step for a patient not adequately controlled on 4mg of perindopril (Angiotensin-Converting Enzyme Inhibitor) for hypertension?
Can a one-time dose of captopril (angiotensin-converting enzyme inhibitor) be given to a patient with hypertension (blood pressure 168/102) who is already on perindopril (angiotensin-converting enzyme inhibitor) and hydrochlorothiazide (HCTZ) (thiazide diuretic), considering a history of asthma?
What is the cause of unilateral ocular pain accompanied by headache?
Can a patient with one of the three peripheral blood findings, hypocellularity below 25%, and fibrosis be diagnosed with a myelodysplastic syndrome (MDS) or myeloproliferative neoplasm if all other conditions are ruled out?
Are there genetic tests associated with Aplastic Anemia (Bone Marrow Failure)?
Can a patient without significant anemia or pancytopenia (a condition characterized by a reduction in the number of red and white blood cells, as well as platelets) still experience symptoms of aplastic anemia, and are these symptoms always related to low blood cell counts?
What is the history of present illness (HPI) for a patient experiencing vertigo (dizziness)?
Is aplastic anemia associated with gastroparesis or gastrointestinal (GI) motility disorders?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.